Summit Securities Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-596
Closed -$4K 721
2024
Q3
$4K Buy
+596
New +$4K ﹤0.01% 324